                         SEQUENCE LISTING

<110>  TAKEDA PHARMACEUTICAL COMPANY LIMITED
 
<120>  RECOMBINANT ANTIGEN PRESENTING CELLS

<130>  3817.085PC01

<150>  US 63/180,530
<151>  2021-04-27

<160>  8     

<170>  PatentIn version 3.5

<210>  1
<211>  162
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human IL-21 Canonical Amino Acid Sequence

<400>  1

Met Arg Ser Ser Pro Gly Asn Met Glu Arg Ile Val Ile Cys Leu Met 
1               5                   10                  15      


Val Ile Phe Leu Gly Thr Leu Val His Lys Ser Ser Ser Gln Gly Gln 
            20                  25                  30          


Asp Arg His Met Ile Arg Met Arg Gln Leu Ile Asp Ile Val Asp Gln 
        35                  40                  45              


Leu Lys Asn Tyr Val Asn Asp Leu Val Pro Glu Phe Leu Pro Ala Pro 
    50                  55                  60                  


Glu Asp Val Glu Thr Asn Cys Glu Trp Ser Ala Phe Ser Cys Phe Gln 
65                  70                  75                  80  


Lys Ala Gln Leu Lys Ser Ala Asn Thr Gly Asn Asn Glu Arg Ile Ile 
                85                  90                  95      


Asn Val Ser Ile Lys Lys Leu Lys Arg Lys Pro Pro Ser Thr Asn Ala 
            100                 105                 110         


Gly Arg Arg Gln Lys His Arg Leu Thr Cys Pro Ser Cys Asp Ser Tyr 
        115                 120                 125             


Glu Lys Lys Pro Pro Lys Glu Phe Leu Glu Arg Phe Lys Ser Leu Leu 
    130                 135                 140                 


Gln Lys Met Ile His Gln His Leu Ser Ser Arg Thr His Gly Ser Glu 
145                 150                 155                 160 


Asp Ser 
        


<210>  2
<211>  162
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human IL-15 Canonical Amino Acid Sequence

<400>  2

Met Arg Ile Ser Lys Pro His Leu Arg Ser Ile Ser Ile Gln Cys Tyr 
1               5                   10                  15      


Leu Cys Leu Leu Leu Asn Ser His Phe Leu Thr Glu Ala Gly Ile His 
            20                  25                  30          


Val Phe Ile Leu Gly Cys Phe Ser Ala Gly Leu Pro Lys Thr Glu Ala 
        35                  40                  45              


Asn Trp Val Asn Val Ile Ser Asp Leu Lys Lys Ile Glu Asp Leu Ile 
    50                  55                  60                  


Gln Ser Met His Ile Asp Ala Thr Leu Tyr Thr Glu Ser Asp Val His 
65                  70                  75                  80  


Pro Ser Cys Lys Val Thr Ala Met Lys Cys Phe Leu Leu Glu Leu Gln 
                85                  90                  95      


Val Ile Ser Leu Glu Ser Gly Asp Ala Ser Ile His Asp Thr Val Glu 
            100                 105                 110         


Asn Leu Ile Ile Leu Ala Asn Asn Ser Leu Ser Ser Asn Gly Asn Val 
        115                 120                 125             


Thr Glu Ser Gly Cys Lys Glu Cys Glu Glu Leu Glu Glu Lys Asn Ile 
    130                 135                 140                 


Lys Glu Phe Leu Gln Ser Phe Val His Ile Val Gln Met Phe Ile Asn 
145                 150                 155                 160 


Thr Ser 
        


<210>  3
<211>  254
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human 4-1BBL Canonical Amino Acid Sequence

<400>  3

Met Glu Tyr Ala Ser Asp Ala Ser Leu Asp Pro Glu Ala Pro Trp Pro 
1               5                   10                  15      


Pro Ala Pro Arg Ala Arg Ala Cys Arg Val Leu Pro Trp Ala Leu Val 
            20                  25                  30          


Ala Gly Leu Leu Leu Leu Leu Leu Leu Ala Ala Ala Cys Ala Val Phe 
        35                  40                  45              


Leu Ala Cys Pro Trp Ala Val Ser Gly Ala Arg Ala Ser Pro Gly Ser 
    50                  55                  60                  


Ala Ala Ser Pro Arg Leu Arg Glu Gly Pro Glu Leu Ser Pro Asp Asp 
65                  70                  75                  80  


Pro Ala Gly Leu Leu Asp Leu Arg Gln Gly Met Phe Ala Gln Leu Val 
                85                  90                  95      


Ala Gln Asn Val Leu Leu Ile Asp Gly Pro Leu Ser Trp Tyr Ser Asp 
            100                 105                 110         


Pro Gly Leu Ala Gly Val Ser Leu Thr Gly Gly Leu Ser Tyr Lys Glu 
        115                 120                 125             


Asp Thr Lys Glu Leu Val Val Ala Lys Ala Gly Val Tyr Tyr Val Phe 
    130                 135                 140                 


Phe Gln Leu Glu Leu Arg Arg Val Val Ala Gly Glu Gly Ser Gly Ser 
145                 150                 155                 160 


Val Ser Leu Ala Leu His Leu Gln Pro Leu Arg Ser Ala Ala Gly Ala 
                165                 170                 175     


Ala Ala Leu Ala Leu Thr Val Asp Leu Pro Pro Ala Ser Ser Glu Ala 
            180                 185                 190         


Arg Asn Ser Ala Phe Gly Phe Gln Gly Arg Leu Leu His Leu Ser Ala 
        195                 200                 205             


Gly Gln Arg Leu Gly Val His Leu His Thr Glu Ala Arg Ala Arg His 
    210                 215                 220                 


Ala Trp Gln Leu Thr Gln Gly Ala Thr Val Leu Gly Leu Phe Arg Val 
225                 230                 235                 240 


Thr Pro Glu Ile Pro Ala Gly Leu Pro Ser Pro Arg Ser Glu 
                245                 250                 


<210>  4
<211>  183
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Human OX40L Canonical Amino Acid Sequence

<400>  4

Met Glu Arg Val Gln Pro Leu Glu Glu Asn Val Gly Asn Ala Ala Arg 
1               5                   10                  15      


Pro Arg Phe Glu Arg Asn Lys Leu Leu Leu Val Ala Ser Val Ile Gln 
            20                  25                  30          


Gly Leu Gly Leu Leu Leu Cys Phe Thr Tyr Ile Cys Leu His Phe Ser 
        35                  40                  45              


Ala Leu Gln Val Ser His Arg Tyr Pro Arg Ile Gln Ser Ile Lys Val 
    50                  55                  60                  


Gln Phe Thr Glu Tyr Lys Lys Glu Lys Gly Phe Ile Leu Thr Ser Gln 
65                  70                  75                  80  


Lys Glu Asp Glu Ile Met Lys Val Gln Asn Asn Ser Val Ile Ile Asn 
                85                  90                  95      


Cys Asp Gly Phe Tyr Leu Ile Ser Leu Lys Gly Tyr Phe Ser Gln Glu 
            100                 105                 110         


Val Asn Ile Ser Leu His Tyr Gln Lys Asp Glu Glu Pro Leu Phe Gln 
        115                 120                 125             


Leu Lys Lys Val Arg Ser Val Asn Ser Leu Met Val Ala Ser Leu Thr 
    130                 135                 140                 


Tyr Lys Asp Lys Val Tyr Leu Asn Val Thr Thr Asp Asn Thr Ser Leu 
145                 150                 155                 160 


Asp Asp Phe His Val Asn Gly Gly Glu Leu Ile Leu Ile His Gln Asn 
                165                 170                 175     


Pro Gly Glu Phe Cys Val Leu 
            180             


<210>  5
<211>  486
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Human IL-21 Canonical Nucleic Acid Sequence

<400>  5
atgcgcagca gcccgggcaa catggaacgc attgtgattt gcctgatggt gatttttctg       60

ggcaccctgg tgcataaaag cagcagccag ggccaggatc gccatatgat tcgcatgcgc      120

cagctgattg atattgtgga tcagctgaaa aactatgtga acgatctggt gccggaattt      180

ctgccggcgc cggaagatgt ggaaaccaac tgcgaatgga gcgcgtttag ctgctttcag      240

aaagcgcagc tgaaaagcgc gaacaccggc aacaacgaac gcattattaa cgtgagcatt      300

aaaaaactga aacgcaaacc gccgagcacc aacgcgggcc gccgccagaa acatcgcctg      360

acctgcccga gctgcgatag ctatgaaaaa aaaccgccga aagaatttct ggaacgcttt      420

aaaagcctgc tgcagaaaat gattcatcag catctgagca gccgcaccca tggcagcgaa      480

gatagc                                                                 486


<210>  6
<211>  486
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Human IL-15 Canonical Nucleic Acid Sequence

<400>  6
atgcgcatta gcaaaccgca tctgcgcagc attagcattc agtgctatct gtgcctgctg       60

ctgaacagcc attttctgac cgaagcgggc attcatgtgt ttattctggg ctgctttagc      120

gcgggcctgc cgaaaaccga agcgaactgg gtgaacgtga ttagcgatct gaaaaaaatt      180

gaagatctga ttcagagcat gcatattgat gcgaccctgt ataccgaaag cgatgtgcat      240

ccgagctgca aagtgaccgc gatgaaatgc tttctgctgg aactgcaggt gattagcctg      300

gaaagcggcg atgcgagcat tcatgatacc gtggaaaacc tgattattct ggcgaacaac      360

agcctgagca gcaacggcaa cgtgaccgaa agcggctgca aagaatgcga agaactggaa      420

gaaaaaaaca ttaaagaatt tctgcagagc tttgtgcata ttgtgcagat gtttattaac      480

accagc                                                                 486


<210>  7
<211>  762
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Human 4-1BBL Canonical Nucleic Acid Sequence

<400>  7
atggaatatg cgagcgatgc gagcctggat ccggaagcgc cgtggccgcc ggcgccgcgc       60

gcgcgcgcgt gccgcgtgct gccgtgggcg ctggtggcgg gcctgctgct gctgctgctg      120

ctggcggcgg cgtgcgcggt gtttctggcg tgcccgtggg cggtgagcgg cgcgcgcgcg      180

agcccgggca gcgcggcgag cccgcgcctg cgcgaaggcc cggaactgag cccggatgat      240

ccggcgggcc tgctggatct gcgccagggc atgtttgcgc agctggtggc gcagaacgtg      300

ctgctgattg atggcccgct gagctggtat agcgatccgg gcctggcggg cgtgagcctg      360

accggcggcc tgagctataa agaagatacc aaagaactgg tggtggcgaa agcgggcgtg      420

tattatgtgt tttttcagct ggaactgcgc cgcgtggtgg cgggcgaagg cagcggcagc      480

gtgagcctgg cgctgcatct gcagccgctg cgcagcgcgg cgggcgcggc ggcgctggcg      540

ctgaccgtgg atctgccgcc ggcgagcagc gaagcgcgca acagcgcgtt tggctttcag      600

ggccgcctgc tgcatctgag cgcgggccag cgcctgggcg tgcatctgca taccgaagcg      660

cgcgcgcgcc atgcgtggca gctgacccag ggcgcgaccg tgctgggcct gtttcgcgtg      720

accccggaaa ttccggcggg cctgccgagc ccgcgcagcg aa                         762


<210>  8
<211>  549
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Human OX40L Canonical Nucleic Acid Sequence

<400>  8
atggaacgcg tgcagccgct ggaagaaaac gtgggcaacg cggcgcgccc gcgctttgaa       60

cgcaacaaac tgctgctggt ggcgagcgtg attcagggcc tgggcctgct gctgtgcttt      120

acctatattt gcctgcattt tagcgcgctg caggtgagcc atcgctatcc gcgcattcag      180

agcattaaag tgcagtttac cgaatataaa aaagaaaaag gctttattct gaccagccag      240

aaagaagatg aaattatgaa agtgcagaac aacagcgtga ttattaactg cgatggcttt      300

tatctgatta gcctgaaagg ctattttagc caggaagtga acattagcct gcattatcag      360

aaagatgaag aaccgctgtt tcagctgaaa aaagtgcgca gcgtgaacag cctgatggtg      420

gcgagcctga cctataaaga taaagtgtat ctgaacgtga ccaccgataa caccagcctg      480

gatgattttc atgtgaacgg cggcgaactg attctgattc atcagaaccc gggcgaattt      540

tgcgtgctg                                                              549


